155 related articles for article (PubMed ID: 37543210)
1. Adenoid 'ameloblastoma': Clinicopathological description of 4 additional BRAF-negative cases.
Khalaj F; Cinel L; Aminishakib P; Mosavat F; Soluk-Tekkesin M
J Stomatol Oral Maxillofac Surg; 2023 Dec; 124(6S):101585. PubMed ID: 37543210
[TBL] [Abstract][Full Text] [Related]
2. Adenoid ameloblastoma with dentinoid is molecularly different from ameloblastomas and adenomatoid odontogenic tumors.
Coura BP; Dos Santos JN; Fonseca FP; Bernardes VF; de Aquino SN; Jorge Júnior J; Vargas PA; Romañach MJ; de Andrade BAB; Gomez RS; Gomes CC
J Oral Pathol Med; 2021 Nov; 50(10):1067-1071. PubMed ID: 34549835
[TBL] [Abstract][Full Text] [Related]
3. Adenoid ameloblastoma harbors beta-catenin mutations.
Bastos VC; Coura BP; Guimarães LM; Fernandes BG; Chan AC; Vargas PA; Bastos-Rodrigues L; De Marco LA; Hellstein J; Thavaraj S; Wright JM; Odell EW; Gomez RS; Gomes CC
Mod Pathol; 2022 Nov; 35(11):1562-1569. PubMed ID: 35840721
[TBL] [Abstract][Full Text] [Related]
4. Adenoid Ameloblastoma with BRAF p.V600E Mutation Revealing Ameloblastomatous Origin: A First Case Report.
Noda Y; Sawada S; Sakagami T; Kojima Y; Higasa K; Tsuta K
Head Neck Pathol; 2023 Sep; 17(3):788-792. PubMed ID: 37093491
[TBL] [Abstract][Full Text] [Related]
5. Ameloblastoma with adenoid features: A series of eight cases.
Adorno-Farias D; Muniz VRVM; Soares AP; Cury PR; Rabelo RG; Fernández-Ramires R; de Azevedo RA; Dos Santos JN
Acta Histochem; 2018 Jul; 120(5):468-476. PubMed ID: 29799420
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic Enigma of Adenoid Ameloblastoma: Literature Review Based Evidence to Consider It as a New Sub Type of Ameloblastoma.
Jayasooriya PR; Abeyasinghe WAMUL; Liyanage RLPR; Uthpali GN; Tilakaratne WM
Head Neck Pathol; 2022 Jun; 16(2):344-352. PubMed ID: 34282559
[TBL] [Abstract][Full Text] [Related]
7. BRAF V600E and previously unidentified KRAS G12C mutations in odontogenic tumors may affect MAPK activation differently depending on tumor type.
Oh KY; Kim JH; Cho SD; Yoon HJ; Lee JI; Hong SD
Genes Chromosomes Cancer; 2022 Aug; 61(8):481-490. PubMed ID: 35353428
[TBL] [Abstract][Full Text] [Related]
8. The diagnostic utility of BRAF VE1 mutation-specific immunohistochemistry in ameloblastoma.
Mendez LD; Wolsefer NS; Asa SL; Wasman J; Yoest JM; Stojanov IJ
Mod Pathol; 2022 Nov; 35(11):1570-1577. PubMed ID: 35676332
[TBL] [Abstract][Full Text] [Related]
9. The BRAF p.V600E mutation is a common event in ameloblastomas but is absent in odontogenic keratocysts.
Zhang R; Yang Q; Qu J; Hong Y; Liu P; Li T
Oral Surg Oral Med Oral Pathol Oral Radiol; 2020 Mar; 129(3):229-235. PubMed ID: 31987674
[TBL] [Abstract][Full Text] [Related]
10. Adenoid Ameloblastoma Versus Dentinogenic Ghost Cell Tumor.
Bastos VC; Gomes CC; Gomez RS
Head Neck Pathol; 2023 Mar; 17(1):275-276. PubMed ID: 36169792
[TBL] [Abstract][Full Text] [Related]
11. Adenoid Ameloblastoma with Dentinoid: A systematic review.
Sachdev SS; Chettiankandy TJ; Sardar MA; Adhane Y; Shah AM; Grace AE
Sultan Qaboos Univ Med J; 2022 Aug; 22(3):325-338. PubMed ID: 36072074
[TBL] [Abstract][Full Text] [Related]
12. BRAF p.V600E mutations are not unique to ameloblastoma and are shared by other odontogenic tumors with ameloblastic morphology.
Brunner P; Bihl M; Jundt G; Baumhoer D; Hoeller S
Oral Oncol; 2015 Oct; 51(10):e77-8. PubMed ID: 26306423
[No Abstract] [Full Text] [Related]
13. Adenoid Ameloblastoma Shares Clinical, Histologic, and Molecular Features With Dentinogenic Ghost Cell Tumor: The Histologic Spectrum of WNT Pathway-Altered Benign Odontogenic Tumors.
Oh KY; Hong SD; Yoon HJ
Mod Pathol; 2023 Mar; 36(3):100051. PubMed ID: 36788106
[TBL] [Abstract][Full Text] [Related]
14. The molecular basis of odontogenic cysts and tumours.
Gomes IP; Bastos VC; Guimarães LM; Gomes CC
J Oral Pathol Med; 2023 Apr; 52(4):351-356. PubMed ID: 36629457
[TBL] [Abstract][Full Text] [Related]
15. [BRAF V600E expression in ameloblastomas, ameloblastic carcinomas and cysts].
Pei J; Zhang L; Jia YX; Chen WH
Shanghai Kou Qiang Yi Xue; 2023 Dec; 32(6):630-634. PubMed ID: 38494972
[TBL] [Abstract][Full Text] [Related]
16. BRAF p.V600E status in epithelial areas of ameloblastoma with different histological aspects: Implications to the clinical practice.
Sant'Ana MSP; Dos Santos Costa SF; da Silva MP; Martins-Chaves RR; Pereira TDSF; de Oliveira EM; Martínez Pedraza R; de Castro WH; Gomes CC; Gomez RS; Fonseca FP
J Oral Pathol Med; 2021 May; 50(5):478-484. PubMed ID: 33377543
[TBL] [Abstract][Full Text] [Related]
17. Detection and evaluation of the presence of the BRAF V600E mutation in ameloblastomas in an Indian population.
Goes CF; Spadigam A; Dhupar A; Carvalho KM; Cota J; Syed S
Indian J Pathol Microbiol; 2023; 66(2):246-251. PubMed ID: 37077063
[TBL] [Abstract][Full Text] [Related]
18. A Systematic Review of Adenoid Ameloblastoma: A Newly Recognized Entity.
de Farias Morais HG; Gonçalo RIC; de Oliveira Costa CS; de Figueiredo Pires H; Mafra RP; de Morais EF; da Costa Miguel MC; de Almeida Freitas R
Head Neck Pathol; 2023 Sep; 17(3):688-696. PubMed ID: 37540485
[TBL] [Abstract][Full Text] [Related]
19. Assessment of BRAFV600E and SMOF412E mutations in epithelial odontogenic tumours.
Diniz MG; Gomes CC; Guimarães BV; Castro WH; Lacerda JC; Cardoso SV; de Faria PR; Dias FL; Eisenberg AL; Loyola AM; Gomez RS
Tumour Biol; 2015 Jul; 36(7):5649-53. PubMed ID: 25854168
[TBL] [Abstract][Full Text] [Related]
20. Adenoid ameloblastoma with dentinoid and cellular atypia: a case report and literature review.
Khalele BAO
Pathologica; 2017 Dec; 109(4):379-381. PubMed ID: 29449727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]